20
Corden Pharma Bergamo Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLOTRIMAZOLE, with a corresponding US DMF Number 10713.
Remarkably, this DMF maintains an Active status since its submission on February 04, 1994, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 29, 2016, and payment made on November 14, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II